Cancer: latest news

Cancer resources

  • Non-HIV-related illnesses – cancers

    Kaposi’s sarcoma and non-Hodgkin’s lymphoma have become rarer since the introduction of effective HIV treatment, but still occasionally cause illness and death in people with HIV. Often, these people...

    From: Living with HIV

    Information level Level 2
  • Cervical and anal screening

    Infection with certain types of a common virus called human papillomavirus, or HPV, can cause cell changes in the cervix that can lead to cervical cancer. All HIV-positive...

    From: Booklets

    Information level Level 2
  • Non-Hodgkin’s lymphoma

    Non-Hodgkin’s lymphoma is an AIDS-defining cancer. A lymphoma is the name given to a tumour (or growth) of lymphocytes (white blood cells). Non-Hodgkin’s lymphoma (NHL)...

    From: Factsheets

    Information level Level 2
  • Kaposi's sarcoma

    Kaposi's sarcoma (KS) is an AIDS-defining cancer and was one of the first recognised HIV-related illnesses in the early 1980s. Unlike most cancers, which start...

    From: Factsheets

    Information level Level 2
  • Lung cancer

    Evidence from the UK and other countries shows that lung cancer is more common in HIV-positive people than the general HIV-negative population. Before effective HIV treatment...

    From: Factsheets

    Information level Level 2
  • Cervical cancer

    Human papillomavirus (HPV) is the underlying cause of cervical cancer. Infection with HPV is very common in the general population and is slightly more common...

    From: Factsheets

    Information level Level 2
  • Anal cancer

    Since potent and effective HIV treatment became available, the number of cases of the AIDS-defining cancers such as Kaposi’s sarcoma and non-Hodgkin’s lymphoma has fallen,...

    From: Factsheets

    Information level Level 2
  • Cancer

    Cancers are a range of diseases caused by uncontrolled cell division. A number of cancers occur more frequently among people with HIV than in the general...

    From: HIV treatments directory

    Information level Level 4
  • Hodgkin's disease

    Hodgkin's disease is a type of lymphoma - a tumour of lymph nodes - named after Thomas Hodgkin, a pathologist who first described it in...

    From: HIV treatments directory

    Information level Level 4
  • Kaposi's sarcoma

    Kaposi's sarcoma (KS) was first described in 1872 by the Hungarian dermatologist Moritz Kaposi. Before the AIDS epidemic it was a rare condition. There are four...

    From: HIV treatments directory

    Information level Level 4
  • Lung cancer

    Lung cancer is not an AIDS-defining illness. However, people with HIV have a greater chance of developing lung cancer than non-infected people, and as...

    From: HIV treatments directory

    Information level Level 4
  • Non-Hodgkin's lymphoma

    Non-Hodgkin's lymphoma (NHL) is a type of lymphoma - a tumour that involves the uncontrolled multiplication of a type of white blood cell called lymphocytes....

    From: HIV treatments directory

    Information level Level 4

Cancer features

Cancer in your own words

Cancer news from aidsmap

More news

Cancer news selected from other sources

  • Heterosexual transmission of HPV to male oral tract via oral/genital route indicated by partner data

    A recent study claims to be the first to have established the association of oral infection in males with sexual behaviour, not just on the basis of their reported sexual behaviour, but through the collection of data from their partners.

    15 December 2014 | BMJ Blogs
  • HIV-infected adults diagnosed with age-related diseases at similar ages as uninfected adults

    HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.

    10 December 2014 | Science Daily
  • HPV vaccine, riskier sexual activity not linked researchers say

    Sexual behavior of teenage girls does not appear to be impacted by the human papilloma virus (HPV) vaccine, according to Queen's University, Canada researchers Drs. Leah Smith and Linda Lévesque.

    09 December 2014 | Eurekalert
  • HIV-positive patients with lymphoma should no longer be excluded from receiving blood stem cell transplants as treatment

    HIV-positive patients with lymphoma were previously excluded from receiving autologous blood stem cell transplants as treatment, because of concern that these patients’ compromised immune systems would have a higher risk of infection and poor graft function due to their need for HIV medications. Results from the clinical trial, presented at the American Society of Hematology (ASH) meetings, show the concern of additional risk is unfounded.

    08 December 2014 | Business Wire (press release)
  • HIV drug blocks bone metastases in prostate cancer

    Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. The receptor CCR5, targeted by HIV drugs, is also key in driving prostate cancer metastases, suggesting that blocking this molecule could slow prostate cancer spread.

    02 December 2014 | Science Daily
  • Gay men 'should get anti-cancer jab'

    The HPV vaccine should be given to men who have sex with men, according to the government's experts. It is is already given to schoolgirls in the UK, but there have been calls for the vaccination programme to be extended. The Joint Committee on Vaccination and Immunisation now recommends offering the jab at sexual health clinics to men who have sex with men, aged between 16 and 40.

    12 November 2014 | BBC News
  • Tobacco use associated with increased risk of oral HPV-16 infection

    Study participants who reported tobacco use or had higher levels of biomarkers of tobacco exposure had a higher prevalence of the sexually transmitted infection, oral human papillomavirus type 16, according to a study in the Oct. 8 JAMA, a theme issue on infectious disease. HPV-16 is the most common cancer-causing variety of HPV.

    08 October 2014 | Eurekalert
  • Population-based evidence for the preventative efficacy of quadrivalent HPV in Australia

    A recently published study claims to provide the first whole population analysis of the impact on genital warts of a national HPV vaccination programme – and this may be the best predictor of the longer-term, and more important, cancer prevention benefits to be seen in future years. The findings show a decline of 89.9% in admissions involving warts from 2006/7 to 2010/11 for girls aged 12-17 yrs, a decline of 72.7% for women aged 18-26, and a decline of 38% for men aged 18-14 (the indirect effect of female vaccination).

    01 October 2014 | BMJ Group blogs
  • Leading parliamentarians support HPV vaccination for boys

    Six leading parliamentarians have today declared their support for vaccinating boys against HPV infection. Their joint statement said: "In our view, all adolescent boys should be offered the vaccine."

    09 September 2014 | HPV Action
  • With advances in HIV care, survivors face other disease risks

    As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

    14 August 2014 | Eurekalert Medicine & Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.